Tag Archives: Neurology Clinical Trials Market

In 2022, the market size for neurology clinical trials is projected to expand at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2023 and 2031. Increasing neurological diseases, such as dementia, stroke, and peripheral neuropathy, and rising R&D expenditures in neurological research are largely responsible for this trend. The “SGT-53 in Children with Recurrent or ...